Minimización de costos de sedación usando anestesia inhalada. Análisis en la UTI durante la pandemia por COVID-19 / Minimization of sedation costs using inhaled anesthesia. Analysis in the ICU during the COVID-19 pandemic / Minimização dos custos de sedação usando anestesia inalatória. Análise na UTI durante a pandemia de COVID-19

Resumen: Introducción: los sedantes de uso no convencional y aquéllos fuera de recomendación como los anestésicos inhalados se usaron ante la escasez de medicamentos durante la pandemia por SARS-CoV-2. Objetivos: comparar el costo y resultados obtenidos con el uso de anestésicos inhalados versus sedantes intravenosos en COVID-19. Material y métodos: estudio retrospectivo en una unidad de terapia intensiva (UTI) de un hospital público de referencia. Se hizo un cálculo de costos de sedación de los dos primeros días de estancia en la UTI. Las dosis de fármacos fueron tomadas del expediente clínico y los costos de adquisición directamente de CompraNet. Se comparan medias de costos por medicamento y por grupo. Resultados: de 151 pacientes, 81 recibieron sedación intravenosa y 70 anestesia inhalada con o sin sedantes intravenosos. No hubo diferencia en mortalidad, días de ventilación mecánica, estancia en la UTI y estancia hospitalaria entre grupos. Se observó una reducción significativa de costos derivados del menor uso de midazolam, propofol y dexmedetomidina (p < 0.0001) cuando se usó anestesia inhalada y una diferencia entre medias de costos totales de sedación de $4,108.42 M.N. por día por paciente. Conclusiones: la anestesia inhalada durante la pandemia por COVID-19 permitió una reducción de costos comparada con sedación intravenosa en los primeros dos días de estancia en la UTI.

Abstract: Introduction: non-conventional sedatives and those off-label, such as inhaled anesthetics, were used due to the shortage of medicines during the SARS-CoV-2 pandemic. Objectives: to compare the cost and results obtained with the use of inhaled anesthetics versus intravenous sedatives in COVID-19. Material and methods: retrospective study in a public reference hospital ICU. A calculation of sedation costs was made of the first two days of ICU stay. Drug doses were taken from the clinical records and acquisition costs directly from CompraNet. Mean costs per medication and per group are compared. Results: of 151 patients, 81 received intravenous sedation and 70 received inhaled anesthesia with or without intravenous sedatives. There was no difference in mortality, days of mechanical ventilation, ICU stay, and hospital stay between groups. A significant reduction in costs derived from the less use of midazolam, propofol and dexmedetomidine (p < 0.0001), and a difference between means of total sedation costs of $4,108.42 Mexican pesos per patient per day was observed with inhaled anesthesia. Conclusions: inhaled anesthesia during the COVID-19 pandemic compared to intravenous sedation allowed a cost reduction in the first two days of ICU stay.

Resumo: Introdução: sedativos de uso não convencional e não recomendados, como anestésicos inalatórios, foram utilizados devido à escassez de medicamentos durante a pandemia de SARS-CoV-2. Objetivos: comparar o custo e os resultados obtidos com o uso de anestésicos inalatórios versus sedativos intravenosos na COVID-19. Material e métodos: estudo retrospectivo em uma UTI de um hospital público de referência. Foi feito um cálculo dos custos de sedação para os dois primeiros dias de internação na UTI. As doses dos medicamentos foram retiradas do prontuário clínico e os custos de aquisição diretamente do CompraNet. Os custos médios por medicamento e por grupo são comparados. Resultados: dos 151 pacientes, 81 receberam sedação intravenosa e 70 anestesia inalatória com ou sem sedativos intravenosos. Não houve diferença na mortalidade, dias em ventilação mecânica, permanência na UTI e internação entre os grupos. Uma redução significativa nos custos derivados do menor uso de midazolam, propofol e dexmedetomidina (p < 0.0001) foi observada quando a anestesia inalatória foi usada e uma diferença entre as médias dos custos totais de sedação de $4,108.42 M.N. por dia por paciente. Conclusões: a anestesia inalatória durante a pandemia de COVID-19 permitiu redução de custos em comparação com a sedação endovenosa nos primeiros dois dias de internação na UTI.

Efecto antagonista del flumazenil sobre el isoflurano en la emersión de la anestesia general / Antagonist effect of flumazenil on isofluran in reversion of general anesthesia

INTRODUCTION AND OBJECTIVES: Isoflurane, an inhalational general anesthetic widely used in medical practice, belonging to the group of volatile liquids together with desflurane and sevoflurane, with various properties including sedation, hypnosis and anesthesia of patients undergoing treatment. surgical acts. Volatile inhalational anesthetics (halogenated) as mechanism of action, has the property of increasing inhibitory synaptic transmission at postsynaptic level by potentiating ion channels regulated by ligand activated by alpha-aminobutyric acid (GABA). Flumazenil is a benzodiazepine antagonist belonging to the group of imidazobenzodiazepine. It is currently known that there is no specific drug capable of antagonizing the effects of halogenates that allow the rapid and complete recovery of general anesthesia, for this reason this work focuses its efforts on demonstrating whether flumazenil has the ability to reverse the actions of the patient. isoflurane and allow an early restoration of the level of consciousness. MATERIAL AND METHODS: The study to be performed is a clinical type of longitudinal, prospective, unicentric and double blind. The sample will be formed by patients who are going to be subjected to a balanced general anesthesia. The sample will be divided into 2 large groups: group C (control) and group F (Flumazenil). At the end of the surgery, the mixture will be administered according to the selected group in a random manner (Flumazenil 0.25 mg or 0.9% solution in a 20 cc syringe) and the time of extubation, recovery time of the level of consciousness, time of discharge UCPA and hemodynamic state (FC, TAM and SO2). RESULTS: The flumazenil group showed a significantly shorter time from injection to extubation than the placebo group (p = 0.007). Differences in terms of shorter times needed to achieve Aldrete of 9 points in the flumazenil group (P = 0.04) were observed as were shorter anesthetic arousal times represented by a Ramsey 2. Heart rate, mean arterial pressure and saturation they had similar values between the 2 groups. CONCLUSION: The study showed that a single dose of 0.25 mg of flumazenil administered at the end of the surgical act, just after completing all surgical stimulation was beneficial (P = 0.007) in the context of extubation times and shorter anesthetic arousal times.

INTRODUCCIÓN Y OBJETIVOS: El isoflurano un anestésico general inhalatorio usado ampliamente en la práctica médica, perteneciente al grupo de los líquidos volátiles junto con el desflurano y sevoflurano, con variadas propiedades entre las que se encuentran la sedación, hipnosis y anestesia de los pacientes sometidos a actos quirúrgicos. Los anestésicos inhalatorios volátiles (halogenados) como mecanismo de acción, tiene la propiedad de aumentar la transmisión sináptica inhibidora a nivel postsináptico potenciando los canales iónicos regulados por ligando activados por ácido alfa-aminobutírico (GABA). El flumazenil es un antagonista benzodiazepínico perteneciente al grupo de los imidazobenzodiazepina. Se conoce actualmente que no existe un fármaco específico capaz de antagonizar los efectos de los halogenados que permitan la recuperación rápida y completa de la anestesia general, por tal motivo este trabajo centra sus esfuerzos en demostrar si el flumazenil tiene la capacidad para revertir las acciones del isoflurane y permitir un restablecimiento temprano del nivel de conciencia. MATERIALES Y MÉTODOS: El estudio a realizar es de tipo clínico de corte longitudinal, prospectivo, unicéntrico y doble ciego. La muestra se conformará por pacientes que vayan a ser sometidos a anestesia general balanceada. Se procederá a dividir la muestra en 2 grandes grupos: grupo C (control) y grupo F (flumazenil). Al final de la cirugía se administrará la mezcla según grupo seleccionado de manera al azar (flumazenil 0,25 mg o solución 0,9% en una jeringa de 20 cc) y se valorará el tiempo de extubación, tiempo de recuperación del nivel de conciencia, tiempo de alta de la UCPA y estado hemodinámico (FC, TAM y SO2). RESULTADOS: El grupo de flumazenil presentó un tiempo desde la inyección hasta la extubación significativamente más bajo que el grupo placebo (p = 0,007). Se observaron diferencias en términos de tiempos más bajos necesario para alcanzar Aldrete de 9 puntos en el grupo flumazenil (P = 0,04) al igual que tiempos de despertar anestésico más cortos representados por un Ramsey 2. La frecuencia cardíaca, presión arterial media y la saturación tuvieron valores similares entre los 2 grupos. CONCLUSIÓN: El estudio demostró que una única dosis de 0,25 mg de flumazenil administrado al final del acto quirúrgico, justo después de culminar toda estimulación quirúrgica fue beneficiosa (P = 0,007) en el contexto de tiempos de extubación y tiempos de despertar anestésico más cortos.

Fulminant hepatic failure after simultaneous kidney-pancreas transplantation: a case report / Insuficiência hepática fulminante após transplante simultâneo de rim-pâncreas: um relato de caso

Abstract We describe an unusual case of hyperacute hepatic failure following general anesthesia in a patient receiving a simultaneous kidney-pancreas transplant. Despite an aggressive evaluation of structural, immunological, viral, and toxicological causes, a definitive cause could not be elucidated. The patient required a liver transplant and suffered a protracted hospital course. We discuss the potential causes of fulminant hepatic failure and the perioperative anesthesia management of her subsequent liver transplantation.

Resumo Descrevemos um caso incomum de insuficiência hepática hiperaguda após a anestesia geral em uma paciente que recebeu um transplante simultâneo de rim-pâncreas. Apesar de uma avaliação agressiva das causas estruturais, imunológicas, virais e toxicológicas, uma causa definitiva não pôde ser identificada. A paciente precisou de um transplante de fígado que resultou em prolongamento da internação hospitalar. Discutimos as potenciais causas da insuficiência hepática fulminante e o manejo da anestesia no período perioperatório de seu subsequente transplante de fígado.

[Fulminant hepatic failure after simultaneous kidney-pancreas transplantation: a case report]. / Insuficiência hepática fulminante após transplante simultâneo de rim­pâncreas: um relato de caso.

We describe an unusual case of hyperacute hepatic failure following general anesthesia in a patient receiving a simultaneous kidney-pancreas transplant. Despite an aggressive evaluation of structural, immunological, viral, and toxicological causes, a definitive cause could not be elucidated. The patient required a liver transplant and suffered a protracted hospital course. We discuss the potential causes of fulminant hepatic failure and the perioperative anesthesia management of her subsequent liver transplantation.

Isoflurane provides neuroprotection in neonatal hypoxic ischemic brain injury by suppressing apoptosis / Isoflurano fornece neuroproteção em lesão cerebral hipóxico-isquêmica neonatal por inibição da apoptose

Abstract Background and objectives: Isoflurane is halogenated volatile ether used for inhalational anesthesia. It is widely used in clinics as an inhalational anesthetic. Neonatal hypoxic ischemia injury ensues in the immature brain that results in delayed cell death via excitotoxicity and oxidative stress. Isoflurane has shown neuroprotective properties that make a beneficial basis of using isoflurane in both cell culture and animal models, including various models of brain injury. We aimed to determine the neuroprotective effect of isoflurane on hypoxic brain injury and elucidated the underlying mechanism. Methods: A hippocampal slice, in artificial cerebrospinal fluid with glucose and oxygen deprivation, was used as an in vitro model for brain hypoxia. The orthodromic population spike and hypoxic injury potential were recorded in the CA1 and CA3 regions. Amino acid neurotransmitters concentration in perfusion solution of hippocampal slices was measured. Results: Isoflurane treatment caused delayed elimination of population spike and improved the recovery of population spike; decreased frequency of hypoxic injury potential, postponed the onset of hypoxic injury potential and increased the duration of hypoxic injury potential. Isoflurane treatment also decreased the hypoxia-induced release of amino acid neurotransmitters such as aspartate, glutamate and glycine induced by hypoxia, but the levels of γ-aminobutyric acid were elevated. Morphological studies showed that isoflurane treatment attenuated edema of pyramid neurons in the CA1 region. It also reduced apoptosis as evident by lowered expression of caspase-3 and PARP genes. Conclusions: Isoflurane showed a neuro-protective effect on hippocampal neuron injury induced by hypoxia through suppression of apoptosis.

Resumo Justificativa e objetivos: Isoflurano é um éter volátil halogenado usado para anestesia por via inalatória. É amplamente usado na clínica como um anestésico para inalação. A lesão hipóxico-isquêmica neonatal ocorre no cérebro imaturo e resulta em morte celular tardia via excitotoxicidade e estresse oxidativo. Isoflurano mostrou ter propriedades neuroprotetoras que formam uma base benéfica para o seu uso tanto em cultura de células quanto em modelos animais, incluindo vários modelos de lesão cerebral. Nosso objetivo foi determinar o efeito neuroprotetor de isoflurano em hipóxia cerebral e elucidar o mecanismo subjacente. Métodos: Fatias de hipocampo, em fluido cerebrospinal artificial (CSFA) com glicose e privação de oxigênio, foram usadas como um modelo in vitro de hipóxia cerebral. O pico de população ortodrômica (PPO) e o potencial de lesão hipóxica (PLH) foram registrados nas regiões CA1 e CA3. A concentração de neurotransmissores de aminoácidos na solução de perfusão das fatias de hipocampo foi medida. Resultados: O tratamento com isoflurano retardou a eliminação do PPO e melhorou a recuperação do PPO; diminuiu a frequência do PLH, retardou o início do PLH e aumentou a duração do PLH. O tratamento com isoflurano também diminuiu a liberação de neurotransmissores de aminoácidos induzida pela hipóxia, como aspartato, glutamato e glicina, mas os níveis de ácido γ-aminobutírico (GABA) estavam elevados. Estudos morfológicos mostram que o tratamento de edema com isoflurano atenuou o edema de neurônios piramidais na região CA1. Também reduziu a apoptose, como mostrado pela expressão reduzida da caspase-3 e genes PARP. Conclusões: Isoflurano mostrou um efeito neuroprotetor na lesão neuronal no hipocampo induzida por hipóxia através da supressão de apoptose.

Isoflurane provides neuroprotection in neonatal hypoxic ischemic brain injury by suppressing apoptosis.

BACKGROUND AND OBJECTIVES: Isoflurane is halogenated volatile ether used for inhalational anesthesia. It is widely used in clinics as an inhalational anesthetic. Neonatal hypoxic ischemia injury ensues in the immature brain that results in delayed cell death via excitotoxicity and oxidative stress. Isoflurane has shown neuroprotective properties that make a beneficial basis of using isoflurane in both cell culture and animal models, including various models of brain injury. We aimed to determine the neuroprotective effect of isoflurane on hypoxic brain injury and elucidated the underlying mechanism. METHODS: A hippocampal slice, in artificial cerebrospinal fluid with glucose and oxygen deprivation, was used as an in vitro model for brain hypoxia. The orthodromic population spike and hypoxic injury potential were recorded in the CA1 and CA3 regions. Amino acid neurotransmitters concentration in perfusion solution of hippocampal slices was measured. RESULTS: Isoflurane treatment caused delayed elimination of population spike and improved the recovery of population spike; decreased frequency of hypoxic injury potential, postponed the onset of hypoxic injury potential and increased the duration of hypoxic injury potential. Isoflurane treatment also decreased the hypoxia-induced release of amino acid neurotransmitters such as aspartate, glutamate and glycine induced by hypoxia, but the levels of γ-aminobutyric acid were elevated. Morphological studies showed that isoflurane treatment attenuated edema of pyramid neurons in the CA1 region. It also reduced apoptosis as evident by lowered expression of caspase-3 and PARP genes. CONCLUSIONS: Isoflurane showed a neuro-protective effect on hippocampal neuron injury induced by hypoxia through suppression of apoptosis.

Comparative immunohistochemical assessment of the effect of repetitive anesthesia with isoflurane and sevoflurane on rat liver / Avaliação imunohistoquímica comparativa do efeito da anestesia repetitiva com isoflurano e sevoflurano sobre o fígado de rato

Abstract Background and objectives: Inhalation anesthetics are used in human, as well as veterinary medical practice. In the present study we investigated the effect of isoflurane and sevoflurane on rat hepatocytes. Methods: A total of 40 Wistar female rats were used in this study. Animals were divided in groups of 5 rats. Groups IM, SM served as control groups. Groups I1, I2, I3 were used to study isoflurane and S1, S2, S3 for sevoflurane study. They were anesthetized 3 times, for 2 h long, at 2 days interval with a concentration of: 1.5% isoflurane (I1, I2, I3) and 2% sevoflurane (S1, S2, S3). The oxygen supply throughout the anesthesia was 1 L O2/min. Groups IM, IS, I1, S1 were sacrificed immediately after the last anesthesia. Groups I2, S2 were sacrificed 6 h after the last anesthesia, and groups I3, S3, 24 h post-anesthesia. Liver samples were harvested to highlight caspase-3 in apoptotic hepatocytes. Results: Following isoflurane administration, there were less than 1% cells in apoptosis highlighted in rat livers from groups IM, I1 and I2. At 24 h post-anesthesia (group I3), a small number of apoptotic hepatocytes was highlighted (around 3.23% cells in apoptosis), with a strictly periacinar disposition, randomly distributed in a small number of hepatic lobules. After sevoflurane administration, less than 1% apoptotic hepatocytes were identified at all control moments throughout the study. Conclusions: The results suggest that the anesthetics do not present a considerable hepatotoxicity. The comparative assessment of the two anesthetics shows that sevoflurane is superior to isoflurane.

Resumo Justificativa e objetivos: Anestésicos inalatórios são usados em humanos e também na prática médica veterinária. No presente estudo investigamos o efeito de isoflurano e sevoflurano em hepatócitos de rato. Métodos: Foram usados neste estudo 40 ratos Wistar fêmeas. Os animais foram divididos em grupos de cinco. Os grupos IM e SM serviram como controle. Os grupos I1, I2 e I3 foram usados para o estudo de isoflurano e os grupos S1, S2 e S3 para o estudo de sevoflurano. Os ratos foram anestesiados três vezes, durante duas horas em intervalos de dois dias, com uma concentração de 1,5% de isoflurano (I1, I2, I3) e 2% de sevoflurano (S1, S2, S3). O fornecimento de oxigênio durante a anestesia foi de 1 L O2/min. Os grupos IM, IS, I1 e S1 foram sacrificados imediatamente após a última anestesia. Os grupos I2 e S2 foram sacrificados seis horas após a última anestesia e os grupos I3 e S3 foram sacrificados 24 horas após a anestesia. Amostras dos fígados foram colhidas para ressaltar a caspase-3 em hepatócitos apoptóticos. Resultados: Após a administração de isoflurano, havia menos de 1% das células em apoptose em destaque nos fígados dos ratos dos grupos IM, I1 e I2. Às 24 horas após a anestesia (grupo I3), um pequeno número de hepatócitos apoptóticos foi destacado (3,23% de células em apoptose), com uma disposição estritamente periacinar, distribuídos aleatoriamente em um pequeno número de lóbulos hepáticos. Após a administração do sevoflurano, menos de 1% de hepatócitos apoptóticos foi identificado em todos os momentos de controle ao longo do estudo. Conclusões: Os resultados sugerem que os anestésicos não apresentam uma hepatotoxicidade considerável. A avaliação comparativa dos dois anestésicos mostra que sevoflurano é superior ao isoflurano.

Comparative immunohistochemical assessment of the effect of repetitive anesthesia with isoflurane and sevoflurane on rat liver.

BACKGROUND AND OBJECTIVES: Inhalation anesthetics are used in human, as well as veterinary medical practice. In the present study we investigated the effect of isoflurane and sevoflurane on rat hepatocytes. METHODS: A total of 40 Wistar female rats were used in this study. Animals were divided in groups of 5 rats. Groups IM, SM served as control groups. Groups I1, I2, I3 were used to study isoflurane and S1, S2, S3 for sevoflurane study. They were anesthetized 3 times, for 2h long, at 2 days interval with a concentration of: 1.5% isoflurane (I1, I2, I3) and 2% sevoflurane (S1, S2, S3). The oxygen supply throughout the anesthesia was 1LO2/min. Groups IM, IS, I1, S1 were sacrificed immediately after the last anesthesia. Groups I2, S2 were sacrificed 6h after the last anesthesia, and groups I3, S3, 24h post-anesthesia. Liver samples were harvested to highlight caspase-3 in apoptotic hepatocytes. RESULTS: Following isoflurane administration, there were less than 1% cells in apoptosis highlighted in rat livers from groups IM, I1 and I2. At 24h post-anesthesia (group I3), a small number of apoptotic hepatocytes was highlighted (around 3.23% cells in apoptosis), with a strictly periacinar disposition, randomly distributed in a small number of hepatic lobules. After sevoflurane administration, less than 1% apoptotic hepatocytes were identified at all control moments throughout the study. CONCLUSIONS: The results suggest that the anesthetics do not present a considerable hepatotoxicity. The comparative assessment of the two anesthetics shows that sevoflurane is superior to isoflurane.

[Isoflurane provides neuroprotection in neonatal hypoxic ischemic brain injury by suppressing apoptosis]. / Isoflurano fornece neuroproteção em lesão cerebral hipóxico­isquêmica neonatal por inibição da apoptose.

BACKGROUND AND OBJECTIVES: Isoflurane is halogenated volatile ether used for inhalational anesthesia. It is widely used in clinics as an inhalational anesthetic. Neonatal hypoxic ischemia injury ensues in the immature brain that results in delayed cell death via excitotoxicity and oxidative stress. Isoflurane has shown neuroprotective properties that make a beneficial basis of using isoflurane in both cell culture and animal models, including various models of brain injury. We aimed to determine the neuroprotective effect of isoflurane on hypoxic brain injury and elucidated the underlying mechanism. METHODS: A hippocampal slice, in artificial cerebrospinal fluid with glucose and oxygen deprivation, was used as an in vitro model for brain hypoxia. The orthodromic population spike and hypoxic injury potential were recorded in the CA1 and CA3 regions. Amino acid neurotransmitters concentration in perfusion solution of hippocampal slices was measured. RESULTS: Isoflurane treatment caused delayed elimination of population spike and improved the recovery of population spike; decreased frequency of hypoxic injury potential, postponed the onset of hypoxic injury potential and increased the duration of hypoxic injury potential. Isoflurane treatment also decreased the hypoxia-induced release of amino acid neurotransmitters such as aspartate, glutamate and glycine induced by hypoxia, but the levels of γ-aminobutyric acid were elevated. Morphological studies showed that isoflurane treatment attenuated edema of pyramid neurons in the CA1 region. It also reduced apoptosis as evident by lowered expression of caspase-3 and PARP genes. CONCLUSIONS: Isoflurane showed a neuro-protective effect on hippocampal neuron injury induced by hypoxia through suppression of apoptosis.

[Comparative immunohistochemical assessment of the effect of repetitive anesthesia with isoflurane and sevoflurane on rat liver]. / Avaliação imunohistoquímica comparativa do efeito da anestesia repetitiva com isoflurano e sevoflurano sobre o fígado de rato.

BACKGROUND AND OBJECTIVES: Inhalation anesthetics are used in human, as well as veterinary medical practice. In the present study we investigated the effect of isoflurane and sevoflurane on rat hepatocytes. METHODS: A total of 40 Wistar female rats were used in this study. Animals were divided in groups of 5 rats. Groups IM, SM served as control groups. Groups I1, I2, I3 were used to study isoflurane and S1, S2, S3 for sevoflurane study. They were anesthetized 3 times, for 2h long, at 2 days interval with a concentration of: 1.5% isoflurane (I1, I2, I3) and 2% sevoflurane (S1, S2, S3). The oxygen supply throughout the anesthesia was 1LO2/min. Groups IM, IS, I1, S1 were sacrificed immediately after the last anesthesia. Groups I2, S2 were sacrificed 6h after the last anesthesia, and groups I3, S3, 24h post-anesthesia. Liver samples were harvested to highlight caspase-3 in apoptotic hepatocytes. RESULTS: Following isoflurane administration, there were less than 1% cells in apoptosis highlighted in rat livers from groups IM, I1 and I2. At 24h post-anesthesia (group I3), a small number of apoptotic hepatocytes was highlighted (around 3.23% cells in apoptosis), with a strictly periacinar disposition, randomly distributed in a small number of hepatic lobules. After sevoflurane administration, less than 1% apoptotic hepatocytes were identified at all control moments throughout the study. CONCLUSIONS: The results suggest that the anesthetics do not present a considerable hepatotoxicity. The comparative assessment of the two anesthetics shows that sevoflurane is superior to isoflurane.

Anestesia geral inalatória ou total intravenosa associada à anestesia subaracnoidea, em ovinos / General inhalation anesthesia or total intravenous associated with subarachnoid anesthesia in sheep

Avaliou-se a eficácia e a segurança anestésica em ovinos mantidos sob anestesia geral inalatória com isofluorano ou anestesia total intravenosa com propofol, ambas associadas à anestesia subaracnoidea. Quatorze ovinos foram pré-medicados com 0,3mg.kg-1 de morfina IM, e cinco minutos após, receberam 20mcg.kg-1 de detomidina IV. Posteriormente, foram alocados aleatoriamente em dois grupos: GISO (n=7), os quais foram induzidos à anestesia geral com 0,5mg.kg-1 de diazepam e 5mg.kg-1 de cetamina IV, e mantidos em anestesia geral inalatória com isoflurano diluído em oxigênio a 100%; e GPRO (n=7), induzidos com 4mg.kg-1 de propofol IV seguido inicialmente de infusão contínua na taxa de 0,3mg.kg-1.min-1. Para realização da osteotomia bilateral, todos os animais receberam 0,5mg.kg-1 de ropivacaína 0,75% associado a 0,1mg.kg-1 de morfina pela via subaracnoidea. Houve redução de 40% nos valores médios de frequência cardíaca após sedação em ambos os grupos, permanecendo em média 23% reduzida até o final da avaliação. A pressão arterial média aumentou 16%, após a indução anestésica no GISO, mas se reduziu até o final do procedimento, assim como no GPRO. A EtISO média foi de 0,57V% e a taxa média de infusão do propofol foi de 0,24mg.kg-1.min-1. Os tempos totais de cirurgia, anestesia e extubação foram de 66±9,8, 92±13,8 e 7,0±1,5 minutos no GISO e 56±2,4, 82,9±4,6 e 5,4±1,5 minutos no GPRO, não havendo diferença significativa entre grupos. A manutenção anestésica com isoflurano ou propofol promoveu plano anestésico similar com mínimos efeitos cardiovasculares ou hemogasométricos, que são bem tolerados em ovinos hígidos.(AU)

The purpose of this study was to evaluate the efficacy and safety of sheep submitted to inhalation anesthesia with isoflurane or total intravenous anesthesia with propofol, both associated with subarachnoid anesthesia. Fourteen animals were pre-medicated with 0.3mg.kg-1 morphine IM, and 5 minutes later received 20mcg.kg-1 detomidine IV. Then they were allocated into two groups: GISO (n=7), which were induced with 0.5mg.kg-1 of diazepam and 5mg.kg-1 of ketamine IV, and anesthesia maintenance was performed by isoflurane diluted in 100% oxygen; or GPRO (n=7), where animals were induced with 4mg.kg-1 propofol IV and subsequent maintenance anesthesia with its own infusion of 0.3mg.kg.min-1. To perform the bilateral tibial osteotomy, all animals received 0.5mg.kg-1 0.75% ropivacaine combined with 0.1mg.kg-1 morphine by the intrathecal route. There was a 40% reduction in mean heart rate after the sedative protocol in both groups, resulting in a 23% average reduction until the end of the review. Mean arterial pressure showed transient elevation of around 16%, after induction of anesthesia in GISO, but reducing it to the end of the procedure, as well as in GPRO. The average EtISO was 0.57 V% and average infusion rate of propofol was 0.24mg.kg-1.min-1. The total time of surgery, anesthesia and extubation was 66± 9.8, 92±7.0 and 13.8±1.5 minutes in GISO and 56±2.4, 82.9±4.6 and 5.4±1.5 minutes in GPRO. The maintenance of anesthesia with propofol or isoflurane produced similar anesthesia with minimal cardiovascular and blood gas effects, which are well tolerated in healthy sheep.(AU)

Anestesia geral inalatória ou total intravenosa associada à anestesia subaracnoidea, em ovinos / General inhalation anesthesia or total intravenous associated with subarachnoid anesthesia in sheep

Avaliou-se a eficácia e a segurança anestésica em ovinos mantidos sob anestesia geral inalatória com isofluorano ou anestesia total intravenosa com propofol, ambas associadas à anestesia subaracnoidea. Quatorze ovinos foram pré-medicados com 0,3mg.kg-1 de morfina IM, e cinco minutos após, receberam 20mcg.kg-1 de detomidina IV. Posteriormente, foram alocados aleatoriamente em dois grupos: GISO (n=7), os quais foram induzidos à anestesia geral com 0,5mg.kg-1 de diazepam e 5mg.kg-1 de cetamina IV, e mantidos em anestesia geral inalatória com isoflurano diluído em oxigênio a 100%; e GPRO (n=7), induzidos com 4mg.kg-1 de propofol IV seguido inicialmente de infusão contínua na taxa de 0,3mg.kg-1.min-1. Para realização da osteotomia bilateral, todos os animais receberam 0,5mg.kg-1 de ropivacaína 0,75% associado a 0,1mg.kg-1 de morfina pela via subaracnoidea. Houve redução de 40% nos valores médios de frequência cardíaca após sedação em ambos os grupos, permanecendo em média 23% reduzida até o final da avaliação. A pressão arterial média aumentou 16%, após a indução anestésica no GISO, mas se reduziu até o final do procedimento, assim como no GPRO. A EtISO média foi de 0,57V% e a taxa média de infusão do propofol foi de 0,24mg.kg-1.min-1. Os tempos totais de cirurgia, anestesia e extubação foram de 66±9,8, 92±13,8 e 7,0±1,5 minutos no GISO e 56±2,4, 82,9±4,6 e 5,4±1,5 minutos no GPRO, não havendo diferença significativa entre grupos. A manutenção anestésica com isoflurano ou propofol promoveu plano anestésico similar com mínimos efeitos cardiovasculares ou hemogasométricos, que são bem tolerados em ovinos hígidos.

The purpose of this study was to evaluate the efficacy and safety of sheep submitted to inhalation anesthesia with isoflurane or total intravenous anesthesia with propofol, both associated with subarachnoid anesthesia. Fourteen animals were pre-medicated with 0.3mg.kg-1 morphine IM, and 5 minutes later received 20mcg.kg-1 detomidine IV. Then they were allocated into two groups: GISO (n=7), which were induced with 0.5mg.kg-1 of diazepam and 5mg.kg-1 of ketamine IV, and anesthesia maintenance was performed by isoflurane diluted in 100% oxygen; or GPRO (n=7), where animals were induced with 4mg.kg-1 propofol IV and subsequent maintenance anesthesia with its own infusion of 0.3mg.kg.min-1. To perform the bilateral tibial osteotomy, all animals received 0.5mg.kg-1 0.75% ropivacaine combined with 0.1mg.kg-1 morphine by the intrathecal route. There was a 40% reduction in mean heart rate after the sedative protocol in both groups, resulting in a 23% average reduction until the end of the review. Mean arterial pressure showed transient elevation of around 16%, after induction of anesthesia in GISO, but reducing it to the end of the procedure, as well as in GPRO. The average EtISO was 0.57 V% and average infusion rate of propofol was 0.24mg.kg-1.min-1. The total time of surgery, anesthesia and extubation was 66± 9.8, 92±7.0 and 13.8±1.5 minutes in GISO and 56±2.4, 82.9±4.6 and 5.4±1.5 minutes in GPRO. The maintenance of anesthesia with propofol or isoflurane produced similar anesthesia with minimal cardiovascular and blood gas effects, which are well tolerated in healthy sheep.

El efecto del flumazenil sobre la recuperación de anestesia general con isoflurano: una prueba aleatoria controlada / Effect of flumazenil on recovery from general anesthesia with isoflurane: A randomized controlled trial

Background and objectives: The inhalational anesthetic isoflurane is widely used in general anesthetics. Its mechanism of action involves interaction with the receptor of gamma-aminobutyric acid (GABA), which is also the binding site for benzodiazepines. Flumazenil, benzodiazepine antagonist, reverses the effects of these drugs in GABA receptors and could therefore also reverse the effect of isoflurane. In anesthesia practice, extubation and early anesthetic recovery reduce morbidity and incidence of complications. The objective of this trial is to determine whether the use of lumazenil may contribute to faster recovery from anesthesia. Methods: Forty patients scheduled to undergo general anesthesia with isolurane were enrolled in this prospective, double-blind, randomized trial. Patients were randomized to receive, at the end of anesthesia, lumazenil or placebo as allocated into two groups. The anesthetic technique was standardized. The groups were compared concerning values of cerebral state index (CSI), heart rate, blood pressure and oxygen saturation from the application of flumazenil or placebo until 30 min after injection. Data regarding time to extubation, time to reach 10 points in the Aldrete-Kroulic score (AK = 10) and Vigilance score (VS = 10) was also collected. ANOVA test was applied to analyze the results, considering p < 0.05. Results:Patients receiving flumazenil achieved faster extubation than the control (p = 0.033). No differences were observed in values of CSI, the time until AK = 10 and until VS = 10. Conclusions: Administration of lumazenil at the end of isolurane general anesthesia resulted in earlier extubation in studied patients.

Introducción y objetivos: El isoflurano es un anestésico inhalatorio ampliamente utilizado en anestesia general. Su mecanismo de acción involucra el receptor del ácido gamma-aminobutírico. Dicho receptor es también el sitio de acción de las benzodiazepinas. El flumazenil, antagonista benzodiazepínico, podría revertir los efectos del isoflurano. En la práctica, la extubación y recuperación anestésica tempranas reducen la morbilidad e incidencia de complicaciones. El objetivo del estudio es determinar la contribución del uso del flumazenil en la recuperación anestésica. Métodos: Se realizó un estudio doble ciego, prospectivo, aleatorio de 40 pacientes bajo anestesia general con isoflurano que recibieron flumazenil o placebo según aleatorización previa. La técnica anestésica fue estandarizada. Los parámetros comparados en los 2 grupos fueron frecuencia cardiaca, tensión arterial, saturación de oxígeno y niveles del Índice Biespectral, desde la aplicación del flumazenil y durante los 30 minutos posteriores. El tiempo transcurrido entre la inyección del medicamento y la extubación, así como el tiempo requerido para alcanzar 10 puntos en la Escala de Aldrete-Kroulic y la Escala de Vigilancia, también fueron contabilizados. El análisis de la varianza fue aplicado para comparar los datos, considerando p<0.05. Resultados: Los pacientes que recibieron flumazenil fueron extubados en menor tiempo que los del grupo placebo (P = 0.033). No se observaron diferencias entre los valores del Índice Biespectral y el tiempo necesario para alcanzar 10 puntos en la Escala de Aldrete-Kroulic y la Escala de Vigilancia. Conclusiones: La administración de flumazenil al final de la anestesia general con isoflurano disminuyó el tiempo a la extubación.

Anestesia em cão nefropata: relato de caso / Anesthesia in renal disease dog: case report / Anestesia en perro con enfermedad renal: reporte de um caso

Anestesia em paciente nefropata é um desafio por muitos anestésicos alterarem a função renal. Devido à escassez de trabalhos na literatura, objetivasse relatar o sucesso do protocolo anestésico utilizado em um cão com doença renal crônica, submetido ao procedimento cirúrgico de nefrotomia direita e nefrectomia esquerda. Foi utilizado isofluorano para manutenção anestésica e infusão contínua de fentanil e lidocaína para a analgesia transoperatória. Foram monitorados ECG, FC, t, Sp02, PAS, pelo método oscilométrico, TR e débito urinário. O protocolo anestésico utilizado possibilitou estabilidade transoperatória dos parâmetros hemodinâmicos avaliados e manutenção do débito urinário.

Anesthesia in renal disease patient is a challenge for many anesthetics af1ect renal function. Due tothe paucity of studies in the literature, the objective is to report the success of the anesthetic protocol used in a dogwitch chronic kidney disease, underwent surgery right nefrotomia and left nephrectomy. It was used anestheticis oflurane for maintenance and continuous infusion of fentanyl and lidocaine for trasnoperatória analgesia. ECGwere monitored, HR, RR, Sp02, SBp, by oscillometry, RT and urinary output. The anesthetic protocol enabled intraoperative stability of the evaluated hemodynamic parameters and normal maintenance of urinary output.

Anestesia en paciente con enfermedad renal es un reto para muchos anestésicos afectan la función renal. Debido a la escasez de estudios en la literatura, el objetivo es dar a conocer el éxito del protocolo anestésico utilizado en perro com una enfermedad renal crônica, se sometió a la cirugía nefrotomia derecha y nefrectomía izquierda. Se utilizó anestesia isoflurano para el mantenimiento y la infusión continua de fentanilo y lidocaína paraperioperatorio analgesia. ECG fueron controlados, FC, FR, Sp02, PAS, por oscilometría, TR y la producción deorina. El protocolo anestésico intraoperatorio activar la estabilidad de los parámetros hemodinámicos evaluados y el mantenimiento de la producción de orina.

Anestesia em cão nefropata: relato de caso / Anesthesia in renal disease dog: case report / Anestesia en perro con enfermedad renal: reporte de um caso

Anestesia em paciente nefropata é um desafio por muitos anestésicos alterarem a função renal. Devido à escassez de trabalhos na literatura, objetivasse relatar o sucesso do protocolo anestésico utilizado em um cão com doença renal crônica, submetido ao procedimento cirúrgico de nefrotomia direita e nefrectomia esquerda. Foi utilizado isofluorano para manutenção anestésica e infusão contínua de fentanil e lidocaína para a analgesia transoperatória. Foram monitorados ECG, FC, t, Sp02, PAS, pelo método oscilométrico, TR e débito urinário. O protocolo anestésico utilizado possibilitou estabilidade transoperatória dos parâmetros hemodinâmicos avaliados e manutenção do débito urinário.(AU)

Anesthesia in renal disease patient is a challenge for many anesthetics af1ect renal function. Due tothe paucity of studies in the literature, the objective is to report the success of the anesthetic protocol used in a dogwitch chronic kidney disease, underwent surgery right nefrotomia and left nephrectomy. It was used anestheticis oflurane for maintenance and continuous infusion of fentanyl and lidocaine for trasnoperatória analgesia. ECGwere monitored, HR, RR, Sp02, SBp, by oscillometry, RT and urinary output. The anesthetic protocol enabled intraoperative stability of the evaluated hemodynamic parameters and normal maintenance of urinary output.(AU)

Anestesia en paciente con enfermedad renal es un reto para muchos anestésicos afectan la función renal. Debido a la escasez de estudios en la literatura, el objetivo es dar a conocer el éxito del protocolo anestésico utilizado en perro com una enfermedad renal crônica, se sometió a la cirugía nefrotomia derecha y nefrectomía izquierda. Se utilizó anestesia isoflurano para el mantenimiento y la infusión continua de fentanilo y lidocaína paraperioperatorio analgesia. ECG fueron controlados, FC, FR, Sp02, PAS, por oscilometría, TR y la producción deorina. El protocolo anestésico intraoperatorio activar la estabilidad de los parámetros hemodinámicos evaluados y el mantenimiento de la producción de orina.(AU)

Evaluation of the isoflurane-sparing effects of a constant rate infusion of remifentanil undergoing mastectomy in dogs / Avaliação da concentração expirada de isoflurano em infusão continua de remifentanil em cadelas submetidas a mastectomia

Os objetivos deste estudo são a avaliação dos efeitos de duas taxas fixas de infusão continua de remifentanil na concentração expirada de isoflurano (ETiso) em cadelas submetidas à mastectomia. Foram utilizadas 18 cadelas, 12+2 anos de idade e pesando 15+5 Kg. Os animais foram distribuídos aleatoriamente em 3 grupos (n=6/grupo) e submetidos à mastectomia unilateral devido a neoplasia mamária. Todos os animais foram pré-medicados com morfina (0,5 mg Kg-1) e acepromazina (0,03 mg Kg-1), ambas por via intramuscular (IM). A indução da anestesia foi realizada com propofol (dose-efeito). Os animais foram intubados e conectados a um sistema circular com reinalação de gases. Foi utilizada ventilação com pressão positiva intermitente para manutenção de normocapnia com fluxo de oxigênio de 2 L/min e FiO2 de 100%. A anestesia foi mantida com isoflurano e solução salina (grupo controle [GCON], n=6) ou infusão intravenosa de remifentanil na taxa de 0,15 ?g Kg-1min-1 (REMI 0,15 n=6) ou 0,3 ?g Kg-1min-1 (REMI 0,3 n=6). As variáveis cardiovasculares e a ETiso foram monitoradas antes e a cada 15 minutos após o início da cirurgia. Os dados foram analisados por ANOVA com repetições múltiplas para comparações entre momentos e ANOVA seguida de teste Student Newman Keuls (p£0.05) para comparações entre grupos. A frequência cardíaca foi menor em todos os momentos nos grupos REMI 0,15 e REMI 0,3 em comparação com GCON, sendo que não foram encontradas diferenças estatísticas para essa variável entre os dois grupos com infusão de remifentanil. Adicionalmente, os valores de pressão arterial (PAS, PAM e PAD) não apresentaram diferenças entre grupos. Os valores basais (antes da cirurgia) de ETiso não apresentaram diferenças entre os 3 grupos. Após o início da cirurgia, a ETiso variou entre 1,37±0,3 e 1,05±0,19 no grupo controle; nos grupos REMI 0,15 e REMI 0,3 a ETiso foi 36,5% e 65,7% menor que no grupo controle (M15).[...](AU)

The aims of this study were to evaluate the effects of two constant rate infusions of remifentanil on end tidal isoflurane (ETiso) in dogs undergoing mastectomy surgery. Eighteen bitches, 12+2 years of age, weighing 15+5 Kg were randomized into 3 groups (n=6/group) and underwent unilateral mastectomy due to mammary neoplasia. All animals received the premedications of morphine (0.5 mg Kg-1) and acepromazine (0.03 mg Kg-1) by intramuscular route (IM). Propofol dose-effect was used for induction of anesthesia. The animals were intubated and connected to a circle breathing system, and IPPV (intermittent positive pressure ventilation) was used to maintain normocapnia with an oxygen flow rate of 2 L/min and FiO2 100%. Anesthesia was maintained with isoflurane and saline solution (control group [GCON], n=6) or intravenous infusion of remifentanil at a rate of 0.15 ?g Kg-1min-1 (REMI 0.15 n=6) or 0.3 ?g Kg-1min-1 (REMI 0.3 n=6). Cardiopulmonary variables and ETiso were monitored before and every 15 minutes after the start of surgery. The data were analyzed by ANOVA with multiple repetitions between moments and ANOVA followed by the Student Newman Keuls test (p£0.05) for comparisons between groups. Heart rate was lower at all moments in the REMI 0.15 and REMI 0.3 groups than in the GCON, and heart rate was not significantly different between the two remifentanil infusion groups. Additionally, the arterial blood pressure values (SAP, MAP and DAP) were not different between all groups. Baseline values (before surgery) of ETiso were not different between the 3 groups. After the start of surgery, ETiso ranged from 1.37±0.3 to 1.05±0.19 in the control group; in the REMI 0.15 and REMI 0.3 groups, ETiso was 36.5% and 65.7% lower than in the control group (M15). Remifentanil infusion reduced ETiso in a dose-dependent manner in animals undergoing radical mastectomy without causing significant cardiopulmonary alterations.(AU)

Evaluation of the isoflurane-sparing effects of a constant rate infusion of remifentanil undergoing mastectomy in dogs / Avaliação da concentração expirada de isoflurano em infusão continua de remifentanil em cadelas submetidas a mastectomia

Os objetivos deste estudo são a avaliação dos efeitos de duas taxas fixas de infusão continua de remifentanil na concentração expirada de isoflurano (ETiso) em cadelas submetidas à mastectomia. Foram utilizadas 18 cadelas, 12+2 anos de idade e pesando 15+5 Kg. Os animais foram distribuídos aleatoriamente em 3 grupos (n=6/grupo) e submetidos à mastectomia unilateral devido a neoplasia mamária. Todos os animais foram pré-medicados com morfina (0,5 mg Kg-1) e acepromazina (0,03 mg Kg-1), ambas por via intramuscular (IM). A indução da anestesia foi realizada com propofol (dose-efeito). Os animais foram intubados e conectados a um sistema circular com reinalação de gases. Foi utilizada ventilação com pressão positiva intermitente para manutenção de normocapnia com fluxo de oxigênio de 2 L/min e FiO2 de 100%. A anestesia foi mantida com isoflurano e solução salina (grupo controle [GCON], n=6) ou infusão intravenosa de remifentanil na taxa de 0,15 ?g Kg-1min-1 (REMI 0,15 n=6) ou 0,3 ?g Kg-1min-1 (REMI 0,3 n=6). As variáveis cardiovasculares e a ETiso foram monitoradas antes e a cada 15 minutos após o início da cirurgia. Os dados foram analisados por ANOVA com repetições múltiplas para comparações entre momentos e ANOVA seguida de teste Student Newman Keuls (p£0.05) para comparações entre grupos. A frequência cardíaca foi menor em todos os momentos nos grupos REMI 0,15 e REMI 0,3 em comparação com GCON, sendo que não foram encontradas diferenças estatísticas para essa variável entre os dois grupos com infusão de remifentanil. Adicionalmente, os valores de pressão arterial (PAS, PAM e PAD) não apresentaram diferenças entre grupos. Os valores basais (antes da cirurgia) de ETiso não apresentaram diferenças entre os 3 grupos. Após o início da cirurgia, a ETiso variou entre 1,37±0,3 e 1,05±0,19 no grupo controle; nos grupos REMI 0,15 e REMI 0,3 a ETiso foi 36,5% e 65,7% menor que no grupo controle (M15).[...]

The aims of this study were to evaluate the effects of two constant rate infusions of remifentanil on end tidal isoflurane (ETiso) in dogs undergoing mastectomy surgery. Eighteen bitches, 12+2 years of age, weighing 15+5 Kg were randomized into 3 groups (n=6/group) and underwent unilateral mastectomy due to mammary neoplasia. All animals received the premedications of morphine (0.5 mg Kg-1) and acepromazine (0.03 mg Kg-1) by intramuscular route (IM). Propofol dose-effect was used for induction of anesthesia. The animals were intubated and connected to a circle breathing system, and IPPV (intermittent positive pressure ventilation) was used to maintain normocapnia with an oxygen flow rate of 2 L/min and FiO2 100%. Anesthesia was maintained with isoflurane and saline solution (control group [GCON], n=6) or intravenous infusion of remifentanil at a rate of 0.15 ?g Kg-1min-1 (REMI 0.15 n=6) or 0.3 ?g Kg-1min-1 (REMI 0.3 n=6). Cardiopulmonary variables and ETiso were monitored before and every 15 minutes after the start of surgery. The data were analyzed by ANOVA with multiple repetitions between moments and ANOVA followed by the Student Newman Keuls test (p£0.05) for comparisons between groups. Heart rate was lower at all moments in the REMI 0.15 and REMI 0.3 groups than in the GCON, and heart rate was not significantly different between the two remifentanil infusion groups. Additionally, the arterial blood pressure values (SAP, MAP and DAP) were not different between all groups. Baseline values (before surgery) of ETiso were not different between the 3 groups. After the start of surgery, ETiso ranged from 1.37±0.3 to 1.05±0.19 in the control group; in the REMI 0.15 and REMI 0.3 groups, ETiso was 36.5% and 65.7% lower than in the control group (M15). Remifentanil infusion reduced ETiso in a dose-dependent manner in animals undergoing radical mastectomy without causing significant cardiopulmonary alterations.

Efeito da associação de morfina-lidocaína-ketamina sobre a função cardiopulmonar e concentração expirada de Isoflurano em ovelhas / Effects of the morphine-lidocaine-ketamine combination on cardiopulmonary function and isoflurane sparing in sheep

Os objetivos deste estudo foram avaliar a redução na concentração expirada de isoflurano, bem como os efeitos clínicos de uma infusão constante de morfina lidocaína cetamina (MLK) em ovinos saudáveis submetidos a cirurgia gastrointestinal experimental. Foram utilizados doze ovinos adultos da raça Texel, fêmeas, pesando 36,5 ± 8,1 kg. Os animais foram anestesiados para implantação de cânulas no duodeno, sendo pré-medicados com morfina 0,3 mg kg-1, pela via intramuscular (IM), e detomidina 20 ug kg- 1 pela via intravenosa (IV). Após a pré-medicação, a anestesia foi induzida com cetamina 5 mg kg 1 e diazepam 0,5 mg kg 1 IV, sendo mantidos com isoflurano em oxigênio a 100%. Após a indução da anestesia os animais foram divididos em dois grupos (n = 6): GMLK (grupo MLK 10 mg de morfina, 150 mg de lidocaína e 30 mg de cetamina foram adicionados em 500 ml de solução salina) que recebeu infusão contínua de MLK na taxa de 10 mL kg 1h-1 durante a manutenção da anestesia; e o GCON (grupo de controle) que recebeu infusão contínua de cloreto de sódio a 0,9% na taxa de 10 mL kg 1h-1 durante a manutenção da anestesia. Os animais foram submetidos à ventilação mecânica. As variáveis cardiopulmonares e concentração de isoflurano ao final da expiração (FEIso) foram avaliados durante o momento basal (imediatamente antes da cirurgia), e 15, 30 e 45 minutos após o início da cirurgia...(AU)

The aims of this study were to evaluate the isoflurane sparing and clinical effects of a constant rate infusion of morphine lidocaine ketamine (MLK) in healthy sheep undergoing experimental gastrointestinal surgery. Twelve adult female sheep (Texel breed) were used, weighing 36.5 ± 8.1 kg. The sheep were anesthetized for the implantation of duodenal cannulas. The sheep were premedicated with 0.3 mg kg-1 intramuscular (IM) morphine and 20 ?g kg-1 intravenous (IV) detomidine. After premedication, anesthesia was induced using 5 mg kg-1 ketamine and 0.5 mg kg-1 diazepam IV and maintained using isoflurane in 100% oxygen. After the induction of anesthesia, the animals were allocated into two groups (each n=6); the GMLK (MLK group 10 mg morphine, 150 mg lidocaine, 30 mg de ketamine were added in 500 mL saline) received a 10 mL kg-1h-1 MLK infusion during the maintenance of anesthesia, and GCON (control group) received 10 mL kg-1h-1 of 0.9% sodium chloride. The animals were mechanically ventilated. Cardiopulmonary variables and end-tidal isoflurane concentration (FE´Iso)  were measured at baseline (immediately before the surgery) and 15, 30 and 45 minutes after initiation of surgery. In GMLK, there was a decrease in the FE´Iso at 15, 30 and 45 minutes, a reduction of up to 75.6% during the surgery. The HR was lower in GMLK compared with GCON at 30 minutes, and the MAP was...(AU)

Efeito da associação de morfina-lidocaína-ketamina sobre a função cardiopulmonar e concentração expirada de Isoflurano em ovelhas / Effects of the morphine-lidocaine-ketamine combination on cardiopulmonary function and isoflurane sparing in sheep

Os objetivos deste estudo foram avaliar a redução na concentração expirada de isoflurano, bem como os efeitos clínicos de uma infusão constante de morfina lidocaína cetamina (MLK) em ovinos saudáveis submetidos a cirurgia gastrointestinal experimental. Foram utilizados doze ovinos adultos da raça Texel, fêmeas, pesando 36,5 ± 8,1 kg. Os animais foram anestesiados para implantação de cânulas no duodeno, sendo pré-medicados com morfina 0,3 mg kg-1, pela via intramuscular (IM), e detomidina 20 ug kg- 1 pela via intravenosa (IV). Após a pré-medicação, a anestesia foi induzida com cetamina 5 mg kg 1 e diazepam 0,5 mg kg 1 IV, sendo mantidos com isoflurano em oxigênio a 100%. Após a indução da anestesia os animais foram divididos em dois grupos (n = 6): GMLK (grupo MLK 10 mg de morfina, 150 mg de lidocaína e 30 mg de cetamina foram adicionados em 500 ml de solução salina) que recebeu infusão contínua de MLK na taxa de 10 mL kg 1h-1 durante a manutenção da anestesia; e o GCON (grupo de controle) que recebeu infusão contínua de cloreto de sódio a 0,9% na taxa de 10 mL kg 1h-1 durante a manutenção da anestesia. Os animais foram submetidos à ventilação mecânica. As variáveis cardiopulmonares e concentração de isoflurano ao final da expiração (FEIso) foram avaliados durante o momento basal (imediatamente antes da cirurgia), e 15, 30 e 45 minutos após o início da cirurgia...

The aims of this study were to evaluate the isoflurane sparing and clinical effects of a constant rate infusion of morphine lidocaine ketamine (MLK) in healthy sheep undergoing experimental gastrointestinal surgery. Twelve adult female sheep (Texel breed) were used, weighing 36.5 ± 8.1 kg. The sheep were anesthetized for the implantation of duodenal cannulas. The sheep were premedicated with 0.3 mg kg-1 intramuscular (IM) morphine and 20 ?g kg-1 intravenous (IV) detomidine. After premedication, anesthesia was induced using 5 mg kg-1 ketamine and 0.5 mg kg-1 diazepam IV and maintained using isoflurane in 100% oxygen. After the induction of anesthesia, the animals were allocated into two groups (each n=6); the GMLK (MLK group 10 mg morphine, 150 mg lidocaine, 30 mg de ketamine were added in 500 mL saline) received a 10 mL kg-1h-1 MLK infusion during the maintenance of anesthesia, and GCON (control group) received 10 mL kg-1h-1 of 0.9% sodium chloride. The animals were mechanically ventilated. Cardiopulmonary variables and end-tidal isoflurane concentration (FE´Iso)  were measured at baseline (immediately before the surgery) and 15, 30 and 45 minutes after initiation of surgery. In GMLK, there was a decrease in the FE´Iso at 15, 30 and 45 minutes, a reduction of up to 75.6% during the surgery. The HR was lower in GMLK compared with GCON at 30 minutes, and the MAP was...

Efectos cardiorespiratorios y requerimientos de isofluorano en conejos sometidos a cirugía oftalmológica tratados con tramadol pre, intra y postoperatorio / Cardiorespiratory effects and isoflurane requirements in rabbits subjected to ophthalmologic surgery treated with tramadol pre-, intra- or postoperatively

Para evaluar los efectos cardiorespiratorios y los requerimientos de isofluorano en conejos sometidos a cirugía oftálmica tratados en diferentes momentos con tramadol, fue realizado un estudio prospectivo experimental de tipo ciego en 24 conejos distribuidos aleatoriamente en tres grupos de ocho individuos cada uno: grupo tramadol preoperatorio (Tpre), grupo tramadol transoperatorio (Ttrans) y grupo tramadol postoperatorio (Tpos). Cada animal recibió tres inyecciones intramusculares de igual volumen en los periodos pre, intra y postoperatorio, conteniendo tramadol (4mg/kg) o NaCl 0,9%, de acuerdo al momento indicado para cada grupo. La inducción y mantenimiento anestésico fueron realizados con isofluorano en FiO2 1,0. Una vez estabilizado el plano anestésico, fue iniciado el procedimiento quirúrgico. Se evaluaron: frecuencia cardíaca (FC), presión arterial media (PAM), frecuencia respiratoria (f), presión de CO2 al final de la expiración (EtCO2), saturación parcial de oxihemoglobina (SpO2) y concentración de isofluorano al final de la expiración (EtISO). Las variables fueron medidas después de la estabilización anestésica (m1) y cada 10 min desde el inicio de la cirugía, hasta el final del experimento (m10 a m40). La FC, SpO2, f , EtCO2 y EtISO fueron similares entre grupos durante todo el tiempo. La PAM fue significativamente mayor (p<0,01) durante m1 comparada con el resto del tiempo y el grupo Tpre mostró valores inferiores (p=0,04) de este parámetro durante m1 con relación a los demás grupos. El clorhidrato de tramadol promueve la reducción transitoria de la presión arterial en conejos anestesiados con isofluorano y sometidos a cirugía oftálmica. La administración preoperatoria del fármaco no disminuye el requerimiento anestésico y resulta en hipotensión más pronunciada. Adicionalmente, la anestesia con isofluorano, asociada al reflejo óculo-cardiaco, generan hipotensión arterial, fenómeno que debe tenerse en cuenta durante cirugías oftalmológicas.

To evaluate the cardiorespiratory effects and isoflurane requirements of tramadol applied at different times during ophthalmic surgery, a blind prospective study was made in 24 rabbits, randomly divided into three groups of eight subjects each: pre-operatory tramadol group (Tpre), trans-operatory tramadol group (Ttrans) and post-operatory tramadol group (Tpos), which received three intramuscular injections of equal volume, in the pre, intra and post-operative period, containing tramadol hydrochloride (4 mg/kg) or NaCl 0,9%, according to each group. Anesthetic induction and maintenance was made with isoflurane diluted FiO2 1.0. Once the anesthetic plane was stabilized, surgical procedure was started. Were evaluated heart rate (HR), medium arterial presseure (MAP), respiratory rate (f), end tidal CO2 (EtCO2), Oxihemoglobin saturation (SpO2) and end tidal isoflurane (EtISO). Variables were measured after anesthesia stabilization (m1) and every 10 min after onset of surgery, until the end of experimental protocol (m10 to m40). HR, SpO2, f, EtCO2 and EtISO were similar among groups at all times. MAP were significantly higher (p<0.01) in m1 than in other moments and Tpre group showed lower (p=0.04) values than the other groups at this moment. Tramadol hydrochloride promotes transient reduction of blood pressure in isoflurane anesthetized rabbits subjected to ophthalmic surgery. The preoperative administration of the drug does not reduce the anesthetic requirement and results in a more pronounced hypotension. Additionally, isoflurane anesthesia, associated to oculocardiac reflex generates a hypotension phenomenon that must be taken in to considertation during ophthalmologic surgeries.